✦ LIBER ✦

Prostatic expression of human 5α-reductase type 2 during finasteride therapy: a randomized, double-blind, placebo-controlled study

✍ Scribed by Markku H. Vaarala; Olavi Lukkarinen; Timo Marttila; Atte P. Kyllönen; Katja S. Porvari; Pirkko T. Vihko

Book ID: 106033665
Publisher: Springer-Verlag
Year: 2000
Tongue: English
Weight: 157 KB
Volume: 18
Category: Article
ISSN: 0724-4983
DOI: 10.1007/s003450000159

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2·5% and prilocaine 2·5% for topical 5-aminolaevulinic acid–photodynamic therapy for extensive scalp actinic keratoses

✍ S.M. Langan; P. Collins 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Golimumab, a human anti–tumor necrosis f

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four–week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

Erratum: Golimumab, a human anti-tumor n

Erratum: Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 1 views